Medicare Enrolled

Dr. Archana Maini, M.D.

Hematology & Oncology · Fort Lauderdale, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Consulting-driven
1625 SE 3RD AVE STE 525, Fort Lauderdale, FL 33316
9543554975
In practice since 2006 (19 years)
NPI: 1942211370 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Maini from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Maini? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Maini

Dr. Archana Maini is a hematology & oncology specialist in Fort Lauderdale, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Maini performed 5,118 Medicare services across 592 unique beneficiaries.

Between the years covered by Open Payments, Dr. Maini received a total of $20,790 from 50 pharmaceutical and/or device companies across 359 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Maini is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 28% volume in FL $20,790 industry payments

Medicare Practice Summary

Medicare Utilization ↗
5,118
Medicare services
Top 28% in FL for hematology & oncology
592
Unique beneficiaries
$35
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~269 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 2,701 $18 $85
Hospital follow-up visit, moderate complexity 531 $61 $100
Hospital follow-up visit, high complexity 465 $92 $125
Office visit, established patient (30-39 min) 333 $88 $514
Blood draw (venipuncture) 317 $8 $11
Complete blood count (CBC) with differential 314 $7 $29
Drug injection, under skin or into muscle 151 $10 $54
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg 95 $1 $20
Administration of chemotherapy into vein, 1 hour or less 70 $90 $585
Initial hospital admission, high complexity 59 $135 $242
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 51 $47 $269
Office visit, established patient, complex (40-54 min) 20 $122 $751
New patient office visit (45-59 min) 11 $116 $675
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.0% high complexity
58.9% medium
40.1% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$20,790
Total received (2018-2024)
Avg $2,970/year across 7 years
Top 25% in FL for hematology & oncology
50
Companies
359
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$13,404 (64.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,650 (32.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$736 (3.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$229
2023
$1,604
2022
$1,768
2021
$1,983
2020
$7,111
2019
$7,595
2018
$500

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$7,849
Ipsen Biopharmaceuticals, Inc
$2,117
GlaxoSmithKline, LLC.
$1,950
Bayer HealthCare Pharmaceuticals Inc.
$1,876
Janssen Biotech, Inc.
$817
AstraZeneca Pharmaceuticals LP
$695
PFIZER INC.
$671
Rigel Pharmaceuticals, Inc.
$483
Celgene Corporation
$366
E.R. Squibb & Sons, L.L.C.
$329
Astellas Pharma US Inc
$289
Incyte Corporation
$263
Merck Sharp & Dohme LLC
$231
Seagen Inc.
$223
Lilly USA, LLC
$207
Exelixis Inc.
$204
Biocompatibles, Inc.
$198
Amgen Inc.
$190
Inari Medical, Inc.
$190
ARRAY BIOPHARMA INC
$177
GENZYME CORPORATION
$155
Eisai Inc.
$152
Merck Sharp & Dohme Corporation
$117
PORTOLA PHARMACEUTICALS, INC.
$97
EISAI INC.
$86
Deciphera Pharmaceuticals Inc.
$75
Pharmacosmos Therapeutics Inc.
$67
Coherus Biosciences Inc.
$57
SOBI, INC
$54
Emmaus Medical, Inc.
$48
Daiichi Sankyo Inc.
$44
Bayer Healthcare Pharmaceuticals Inc.
$41
Karyopharm Therapeutics Inc.
$41
EMD Serono, Inc.
$40
Puma Biotechnology, Inc.
$36
Sobi, Inc
$34
Dova Pharmaceuticals
$31
Bard Peripheral Vascular, Inc.
$30
SANOFI-AVENTIS U.S. LLC
$29
Adaptive Biotechnologies Corporation
$29
Global Blood Therapeutics, Inc.
$28
Acceleron Pharma, Inc.
$22
BeiGene USA, Inc.
$22
Boehringer Ingelheim Pharmaceuticals, Inc.
$20
Takeda Pharmaceuticals U.S.A., Inc.
$20
Agios Pharmaceuticals, Inc.
$20
Sun Pharmaceutical Industries Inc.
$20
Mirati Therapeutics, Inc.
$19
BTG INTERNATIONAL, INC.
$16
Halozyme Inc
$16
Top 3 companies account for 57.3% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · BAVENCIO · BEVYXXA · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CROSSER · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · EKOSONIC · ELITEK · ERLEADA · EVENITY · Endari · Enhertu · FLOWTRIEVER CATHETER · GILOTRIF · Hylenex · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · JAKAFI · KEYTRUDA · KISQALI · KRAZATI · LIBTAYO · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MONOFERRIC · NERLYNX · NINLARO · Nplate · Nubeqa · ONIVYDE · ONUREG · OPDIVO · OXBRYTA · PADCEV · PEMAZYRE · PROMACTA · PYRUKYND · Padcev · Pomalyst · Prolia · QINLOCK · REBLOZYL · RETEVMO · Reblozyl · Revlimid · Rezlidhia · S · SARCLISA · SOMATULINE DEPOT · Stivarga · TABRECTA · TAGRISSO · TASIGNA · THERASPHERE - BIO · TUKYSA · Tavalisse · Udenyca · VERZENIO · Vitrakvi · Voraxaze · XALKORI · XPOVIO · XTANDI · Xospata · Xtandi · YONSA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (64%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.

Equivalent to $406 per 100 Medicare services performed
Looking for a hematology & oncology specialist in Fort Lauderdale?
Compare hematology & oncology specialists in the Fort Lauderdale area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
161
Per 100K population
8.3
County median income
$74,534
Nearest hospital
BROWARD HEALTH MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Maini is a mixed practice specialist, with above-average Medicare volume (top 28% in FL), with consulting-driven industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Maini experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Maini performed 2,701 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Maini receive payments from pharmaceutical companies?
Yes. Dr. Maini received a total of $20,790 from 50 companies across 359 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Maini's costs compare to other hematology & oncology specialists in Fort Lauderdale?
Dr. Maini's average Medicare payment per service is $35. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Maini) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →